StephN
07-12-2013, 02:08 PM
HER2 Metastatic Breast Cancer Advisory Board – Patients Needed
Genentech is seeking patients with metastatic breast cancer who have been on or are currently taking Perjeta and/or Kadcyla. They will be hosting an advisory board to include the patient perspective in the planning process for HER2 and equip patients with knowledge about HER2 therapies. Please reach out to jross@webershandwick.com (jross@webershandwick.com) for additional information.
Genentech is seeking patients with metastatic breast cancer who have been on or are currently taking Perjeta and/or Kadcyla. They will be hosting an advisory board to include the patient perspective in the planning process for HER2 and equip patients with knowledge about HER2 therapies. Please reach out to jross@webershandwick.com (jross@webershandwick.com) for additional information.